room grow possibility certain oncogenic mutations cancer stem cells permit adapt different niche letting increase numbers expand territory alternative mutations allow cancer stem cells independent niche signals altogether lifting environmental controls self renewal proliferation implications stem cell model cancer way understand treat malignancies clear dramatic current therapies aim tumor cells studies shown minor fraction cancer cells ability reconstitute perpetuate malignancy traditional therapies shrink tumor miss cells cancer likely return shideng bao jeremy n. rich colleagues duke university showed case glioblastoma stem cells resistant radiation treatments specifically target cancer stem cells destroy engine driving disease leaving remaining nontumorigenic cells eventually die